Abstract Coronavirus disease 2019 (COVID‐19) is an acute respiratory infectious disease
caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). COVID‐19 …

As a result of cross-species transmission in December 2019, the coronavirus disease 2019
(COVID-19) became a serious endangerment to human health and the causal agent of a …

One of the main causes of acute respiratory distress syndrome in coronavirus disease 2019
(COVID-19) is cytokine storm, although the exact cause is still unknown. Umbilical cord …

The aim of this clinical trial was to control the cytokine storm by administering mesenchymal
stem cells (MSCs) to critically-ill COVID-19 patients, to evaluate the healing effect, and to …

Over the past years, biomaterials-based nano cues with multi-functional characteristics have
been engineered with high interest. The ease in fine tunability with maintained compliance …

Abstract Coronavirus disease 2019 (COVID-19) caused by the novel severe acute
respiratory coronavirus 2 is currently spreading throughout the world with a high rate of …

Mesenchymal stem cell (MSC) therapy is considered one of the most promising treatments
in the context of the coronavirus disease 2019 (COVID-19) pandemic. However, the safety …

Pulmonary fibrosis due to COVID-19 is recognized as sequel of ARDS characterized by
failed alveolar reepithelization, fibroblast activation, excessive collagen deposition and other …

The therapeutic value of mesenchymal stem cells (MSCs) for the treatment of infectious
diseases and the repair of disease-induced tissue damage has been explored extensively …

Abstract Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) virus is a highly
contagious microorganism, and despite substantial investigation, no progress has been …